The promise of selective aldosterone synthase inhibition for the management of resistant hypertension. Volpe M, Patrono C. Eur Heart J 2022 Dec 20:ehac754. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Volpe M, Patrono C. The promise of selective aldosterone synthase inhibition for the management of resistant hypertension. Eur Heart J 2022 Dec 20:ehac754. doi: 10.1093.
PMID: 36540035